Cargando…

Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients

Skin rash is a well-known predictive marker of the response to cetuximab (Cmab) in metastatic colorectal cancer (mCRC). However, the mechanism of skin rash development is not well understood. Following exposure to EGFR-targeted therapies, changes in IL-8 levels have been reported. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jin Hyun, Kim, Mi Young, Choi, In Sil, Kim, Ji-Won, Kim, Jin Won, Lee, Keun-Wook, Kim, Jin-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586384/ https://www.ncbi.nlm.nih.gov/pubmed/36269747 http://dx.doi.org/10.1371/journal.pone.0276497

Ejemplares similares

Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance
por: Tak, Eunyoung, et al.
Publicado: (2022)

Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer
por: Kim, Sang-A, et al.
Publicado: (2021)

Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer
por: Kim, Dalyong, et al.
Publicado: (2017)

Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling
por: Chang, Jae Won, et al.
Publicado: (2015)

Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment
por: Kim, Hyung-Don, et al.
Publicado: (2022)

Effect of Methyl Gallate on 1-Nitropyrene-Induced Keratinocyte Toxicity in a Human and Canine Skin Model
por: Lee, Woo Jin, et al.
Publicado: (2022)

PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells
por: Lee, Hyun Jung, et al.
Publicado: (2020)

Identification of a potentially avoidable cardiopulmonary resuscitation in hematology and oncology wards
por: Choi, Yeonjoo, et al.
Publicado: (2019)

Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth
por: Jeoung, Mee Hyun, et al.
Publicado: (2019)

A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study
por: Choi, In Sil, et al.
Publicado: (2018)

Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan
por: Kim, Seung Tae, et al.
Publicado: (2015)

Use of a High-Throughput Genotyping Platform (OncoMap) for RAS Mutational Analysis to Predict Cetuximab Efficacy in Patients with Metastatic Colorectal Cancer
por: Kim, Dalyong, et al.
Publicado: (2017)

The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Kim, Seung Tae, et al.
Publicado: (2017)

Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells
por: Kang, Mi Hyun, et al.
Publicado: (2016)

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study
por: Choi, In Sil, et al.
Publicado: (2018)

A Phase II Study of Cetuximab (Erbitux®) plus FOLFIRI for Irinotecan and Oxaliplatin-refractory Metastatic Colorectal Cancer
por: Koo, Dong Hoe, et al.
Publicado: (2007)

Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer
por: Moon, Ji Wook, et al.
Publicado: (2014)

Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
por: Baas, Jara, et al.
Publicado: (2018)

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
por: Bray, Steven M., et al.
Publicado: (2019)

An Overview of Carcinogenic Heavy Metal: Molecular Toxicity Mechanism and Prevention
por: Kim, Hyun Soo, et al.
Publicado: (2015)

Comparison of efficacy and tolerance between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer: Study protocol for a randomized controlled trial
por: Lee, Keun-Wook, et al.
Publicado: (2017)

Utilizing the algicidal activity of aminoclay as a practical treatment for toxic red tides
por: Lee, Young-Chul, et al.
Publicado: (2013)

The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Yang, Jieun, et al.
Publicado: (2022)

Oral Toxicity and Intestinal Transport Mechanism of Colloidal Gold Nanoparticle-Treated Red Ginseng
por: Bae, Song-Hwa, et al.
Publicado: (2016)

Aquatic Toxicity Assessment of Phosphate Compounds
por: Kim, Eunju, et al.
Publicado: (2013)

Combined Toxic Effects of Polar and Nonpolar Chemicals on Human Hepatocytes (HepG2) Cells by Quantitative Property-Activity Relationship Modeling
por: Kim, Ki-Woong, et al.
Publicado: (2016)

Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome
por: Park, Sehhoon, et al.
Publicado: (2016)

p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Kim, Se Hyun, et al.
Publicado: (2016)

The Riddle of Cetuximab-Related Skin Toxicity: (1)H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients
por: Saorin, Asia, et al.
Publicado: (2022)

Toxicity and Biokinetics of Colloidal Gold Nanoparticles
por: Jo, Mi-Rae, et al.
Publicado: (2015)

Inducing re-epithelialization in skin wound through cultured oral mucosal keratinocytes
por: Kim, Hyun Sil, et al.
Publicado: (2013)

Changes in the Brain Metabolism Associated with Central Post-Stroke Pain in Hemorrhagic Pontine Stroke: An (18)F-FDG-PET Study of the Brain
por: Choi, Soo-jin, et al.
Publicado: (2022)

Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer
por: Park, Seong Hye, et al.
Publicado: (2019)

Whole Transcriptome Analysis Identifies TNS4 as a Key Effector of Cetuximab and a Regulator of the Oncogenic Activity of KRAS Mutant Colorectal Cancer Cell Lines
por: Kim, Sujin, et al.
Publicado: (2019)

Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer
por: Liang, Li, et al.
Publicado: (2021)

Adipose-Derived Stem Cells Improve Efficacy of Melanocyte Transplantation in Animal Skin
por: Lim, Won-Suk, et al.
Publicado: (2014)

Developmental Toxicity of Zinc Oxide Nanoparticles to Zebrafish (Danio rerio): A Transcriptomic Analysis
por: Choi, Jin Soo, et al.
Publicado: (2016)

Targeted exome sequencing for the identification of a protective variant against Internet gaming disorder at rs2229910 of neurotrophic tyrosine kinase receptor, type 3 (NTRK3): A pilot study
por: Kim, Jeong-Yu, et al.
Publicado: (2016)

Oral Toxicity Study and Skin Sensitization Test of a Cricket
por: Ryu, Hyeon Yeol, et al.
Publicado: (2016)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_mu4bv4h0v7h23gtsat8ra17l2j